OSLM
Outcome Studies
in Laboratory Medicine
guest
👤
Learn more about this platform
c
Categories
p
Projects
Trial protocol
Highlighted
Study Design
RCT
Cluster RCT
Observational
Model
Meta-analysis
Review
Guideline
Outcomes
Change patient management
Clinical outcomes
Economics
Operational efficiencies
Patient-centeredness
Safety
Guide Policy Making
Other
Uncategorized
Antibiotic Guidance
ACT Guided Heparinization
Cancer
COVID-19
Cardiovascular Disease
Diabetes
HIV POCT
Inflammatory Bowel Disease
Liver Disease
Kidney Disease
Newborn Screening
MALDI-TOF MS For Microorganism Identification
Preeclampsia
Pharmacogenetic and Pharmacogenomics
Therapeutic drug monitoring
Viscoelastic Testing
Please contact us for any suggestions
Zhen Zhao
Smeralda Skenderaj
Search
Search
Project:
Cancer
Categories:
Review
Economics
6 Publications
found
Diagnostic and economic value of biomarker testing for targetable mutations in non-small-cell lung cancer: a literature review.
b
Future oncology (London, England)
February 1, 2022
p
Cancer
c
Economics
Review
Cost-effectiveness of precision diagnostic testing for precision medicine approaches against non-small-cell lung cancer: A systematic review.
b
Molecular oncology
October 1, 2021
p
Cancer
c
Economics
Review
How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review.
b
BMC cancer
September 1, 2021
p
Cancer
c
Economics
Review
Plasma EGFR mutation testing in non-small cell lung cancer: A value proposition.
b
Clinica chimica acta; international journal of clinical chemistry
August 1, 2019
p
Cancer
c
Change patient management
Clinical outcomes
Economics
Guide Policy Making
Review
Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
b
Health technology assessment (Winchester, England)
May 1, 2017
p
Cancer
c
Economics
Review
Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis.
b
Health technology assessment (Winchester, England)
May 1, 2014
p
Cancer
c
Economics
Review
